Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma. Have a read: https://www.m3india.in/contents/journal/peripheral-and-local-predictive-immune-signatures?utm_campaign=unset&utm_medium=share&utm_source=ref_wa